Board Of Directors
Veterinary Recombinant Biologics
Mirataz™ (mirtazapine transdermal ointment)
Zimeta™ (dipyrone injection)
epoCat™ (feline recombinant erythropoietin)
SEC Filings and Governance
You are here:
We’d love to hear from you! Send us an email or give us a call, we would be happy to answer your questions.
Please provide an email address where we can contact you
Please subscribe me to your mailing list
Yes, I would occasionally like to receive communications about KindredBio products, news and company updates.
No, thank you.
This iframe contains the logic required to handle AJAX powered Gravity Forms.
1555 Bayshore Hwy, Suite 200
Burlingame, California 94010
Tel (650) 701-7901
Looking for information about Investor Relations?
Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit
March 16, 2017 - 4:02 pm
Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotion Pathology
March 7, 2017 - 8:34 am
Kindred Biosciences Announces Fourth Quarter and Year-End 2016 Financial Results
March 1, 2017 - 4:06 pm
Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2016 Financial Results
February 21, 2017 - 8:34 am
Event: Kindred Biosciences to Present Zimeta Pivotal Data at the 62nd Annual American Association of Equine Practitioners Convention
November 29, 2016 - 9:08 am
Event: Kindred Biosciences to Present at 9th Annual LD Micro Investor Conference
November 18, 2016 - 9:04 am
Announcing our new website:
Scroll to top